Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sihuan Pharmaceutical Holdings Group Ltd.
DescriptionCerebroprotein hydrosylate injection
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard Indication Neurology (unspecified)
Indication DetailsTreat brain cell dysfunction caused by cerebrovascular disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today